Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...

Having had a front seat view to the struggles faced by patients suffering from poor circulation, two young medical doctors have partnered to make compression therapy more affordable and accessible to ...

A 1000 ng/mL D-dimer threshold safely rules out pulmonary embolism in low-likelihood patients, reducing unnecessary chest imaging in emergency care.

The season is over for Washington Wizards forward Cam Whitmore, as he recovers from a frightening injury setback. “Washington ...

Boston Scientific (NYSE:BSX) today announced a definitive agreement to acquire cardiovascular disease treatment device maker ...

Boston Scientific said on Thursday that it has agreed to buy thrombectomy company Penumbra in a $14.5bn deal. Penumbra is focused on developing technologies for challenging medical conditions such as ...

The proportion of patients with postoperative pulmonary complications in the first 5 days after thoracic surgery did not ...

Boston Scientific Corporation and Penumbra, Inc. announced that the companies have entered into a definitive agreement under ...

The Washington Wizards announced that forward Cam Whitmore will miss the remainder of the season as he recovers from an ...

Boston Scientific’s $374/share Penumbra deal boosts mechanical thrombectomy exposure and growth. Click here to learn more ...

Boston Scientific to acquire thrombectomy firm Penumbra for $14.5bn, expanding its cardiovascular portfolio as deal reshapes ...

The mother and daughter received identical diagnoses just over a year apart of multiple myeloma, a blood cancer that occurs ...